Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOMAC/E2 versus LNG/EE effects on hemostasis and metabolic parameters in healthy women using oral contraception
2006-000676-33Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nomegestrol, estradiol, avatrombopag and ethinyl estradiol in contraception (2 arms), sponsored by Organon & Co. Primary endpoints: Hemostasis parameters, Lipid parameters and 3 more. Started Jul 2006; status: completed.
02
Drugs
nomegestrolestradiolavatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on 2006-000676-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000676-33.